% Expired Patents = 100.0

CIPO Patents = 1

Forward Citations = 7

Loading Chart...

2 inventors (with patents filed for the assignee):

Robert L Lewis (7 out of 11 patents)

Charles E Day (3 out of 23 patents)

7 patents: Sort by Forward Citations

1. 10150784 - Crystal polymorph of magnesium glycinate dihydrate and process for its preparation (2018-12-11),

2. 9937134 - Hyaluronate compositions (2018-04-10),

3. 9889157 - Phosphate-binding magnesium salts and uses thereof (2018-02-13),

4. 9610267 - Phosphate-binding magnesium salts and uses thereof (2017-04-04),

5. 9394318 - Crystal polymorph of magnesium glycinate dihydrate and process for its preparation (2016-07-19),

6. 9339481 - Phosphate-binding magnesium salts and uses thereof (2016-05-17),

7. 8466128 - Hyaluronate compositions (2013-06-18),

Cypress Pharmaceuticals, Inc. is a leading pharmaceutical company dedicated to developing innovative solutions to improve the health and well-being of patients. With a focus on research and development, Cypress Pharmaceuticals is committed to delivering high-quality medications that meet the needs of healthcare professionals and patients alike. Visit our website to learn more about our products and commitment to excellence.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

7 Patents

#27 in Morristown, NJ

#1,480 in New Jersey

#39,856 in US

Morristown, NJ, United States of America

Cypress Pharmaceuticals, Inc.

Forward Citations = 7

2 inventors:

Robert L Lewis (7 out of 11 patents)

Charles E Day (3 out of 23 patents)

Please report any incorrect information to [email protected]

1 patent (CIPO):

Please report any incorrect information to [email protected]